Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-04-019769
Filing Date
2004-04-06
Accepted
2004-04-06 19:08:31
Documents
1
Period of Report
2004-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 14568
  Complete submission text file 0001209191-04-019769.txt   16438
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O OSI PHARMACEUTICALS INC 58 S SERVICE RD MELVILLE NY 11747
Business Address
GIBSON NEIL (Reporting) CIK: 0001220036 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-15190 | Film No.: 04721173